Cantor Fitzgerald Starts Braveheart Bio (BRVE) at Overweight Aug 31, 2026 06:37AM
Braveheart Bio raises $439.9M in upsized Nasdaq IPO Aug 7, 2026 04:05PM
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Aug 7, 2026 04:05PM
Braveheart Bio shares surge 68% in New York trading debut Aug 6, 2026 01:08PM
Braveheart Bio prices IPO at $18 per share, raises $382.5M Aug 5, 2026 10:33PM


Aug 5, 2026 10:33PM Braveheart Bio Announces Pricing of Upsized Initial Public Offering
Aug 5, 2026 10:26AM Braveheart Bio reportedly pricing IPO above marketing range